Preparation and Characterization of Florfenicol/Chitosan-stearic Acid Polymer Nanomicelle and Its Antibiotic Properties

Abstract

Amphiphilic CS-SA polymers were prepared using the SA modified by small molecule water-soluble chitosan, and CS-SA nanomicelles and FF/CS -SA nanomicelles were prepared by using CSSA polymers as the material with dialysis-ultrasound method. CS-SA polymers, CS-SA nanomicelles, and FF/CS-SA nanomicelles were characterized by FT-IR, TGA, and SEM. Results showed that the SA was grafted to the amino of CS by amide bond. CS-SA nanomicelles and FF/CS-SA nanomicelles were spherical, smooth without fold. The influence of different molar ratio of FF to CS-SA polymers on the encapsulation efficiency and drug-loading rate determined the best molar ratio that was 1:1.09. In vitro release experiments, drug release performance study found that hydrophobic drug releasing from FF/CS-SA nanomicelles presented sustained-release. In vitro bacteriostasis experiments, when the concentration was higher than 4.98 mg/mL, FF/CS-SA nanomicelles had antibacterial action and a positive correlation with concentration. The results revealed that amphiphilic chitosan derivative nanomicelles were carriers with broad prospects, increasing solubility of hydrophobic drugs and presenting sustained release for hydrophobic drugs, which provided a new research idea for drug delivery and targeted drug delivery of hydrohobic drugs.

Keywords

nanomicelle / water-soluble chitosan / hydrophobic drug / antibacterial activity

References

[1] Tao X, Yu X, Zhang D, et al. Development of a Rapid Chemiluminescent CiELISA for Simultaneous Determination of Florfenicol and Its Metabolite Florfenicol Amine in Animal Meat Products[J]. Journal of the Science of Food and Agriculture, 2014, 94: 301-307.

[2] Adams PE, Varma KJ, Powers TE, et al. Tissue Concentrations and Pharmacokinetics of Florfenicol in Male Veal Calves Given Repeated Doses[J]. American Journal of Veterinary Research, 1987, 48(12): 1725-1732.

[3] Miranda CD, Rojas R. Occurrence of Florfenicol Resistance in Bacteria Associated with Two Chilean Salmon Farms with Different History of Antibacterial Usage[J]. Aquaculture, 2007, 266: 39-46.

[4] Shin SJ, Kang SG, Nabin R, et al. Evaluation of The Antimicrobial Activity of Florfenicol Against Bacteria Isolated from Bovine and Porcine Respiratory Disease[J]. Veterinary Microbiology, 2005, 106: 73-77.

[5] Hoar BR, Jelinski MD, Ribble CS, et al. A Comparison of The Clinical Field Efficacy and Safety of Florfenicol and Tilmicosin for The Treatment of Undifferentiated Bovine Respiratory Disease of Cattle in Western Canada[J]. Canadian Veterinary Journal La Revue Vetrinaire Canadienne, 1998, 39: 161-166.

[6] Samuelsen OB, Bergh O. Efficacy of Orally Administered Florfenicol and Oxolinic Acid for The Treatment Ofvibriosis in Cod (Gadus Morhua)[J]. Aquaculture, 2004, 235: 27-35.

[7] Ueda Y, Suenaga I. In Vitro Antibacterial Activity of Florfenicol Against Actinobacillus Pleuropneumoniae[J]. Journal of Veterinary Medical Science, 1995, 57: 363-364.

[8] Li Y, Chen X, Sun G, et al. The Aggregation Behavior and Formation of Nanoparticles of Oleoylchitosan in Dilute Aqueous Solution[J]. Journal of Ocean University of China, 2008, 7: 119-204.

[9] Kevin A J, Marie P, et al. Chitosan Nanoparticles as Delivery Systems for Doxorubicin[J]. Journal of Controlled Release Offcial Journal of Controlled Release Society, 2001, 73: 255-267.

[10] Modaresi SMS, Mehr SE, Faramarzi MA, et al. Preparation and Characterization of Self-Assembled Chitosan Nanoparticles for The Sustained Delivery of Streptokinase: An In vivo Study[J]. Pharmaceutical Development and Technology, 2014, 19(5): 593-597.

[11] Felt O, Buri P, Gurny R. Chitosan: a Unique Polysaccharide for Drug Delivery[J]. Drug Development and Industrial Pharmacy, 1998, 24: 979-993.

[12] Hirano S. Chitin and Chitosan as Novel Biotechnological Materials[J]. Polymer International, 1999, 48: 732-734.

[13] Pillai CKS, Paul W, Sharma CP. Chitin and Chitosan Polymers: Chemistry, Solubility and Fiber Formation[J]. Progress in Polymer Science, 2009, 34: 641-678.

[14] Singla AK, Chawla M. Chitosan: Some Pharmaceutical and Biological Aspects–an Update[J]. Journal of Pharmacy and Pharmacology, 2001, 53: 1047-1067.

[15] Wang F, Zhang D, Duan C, et al. Preparation and Characterizations of a Novel Deoxycholic Acid-O-Carboxymethylated Chitosan-Folic Acid Conjugates and Self-Aggregates[J]. Carbohydrate Polymers, 2011, 84: 1192-1200.

[16] Na SY, Shang XJ, Yan FL. Study on Preparation and Characteristics of Florfenicol/β-Cyclodextrin Inclusion Complexes[J]. Hubei Agricultural Sciences, 2011, 50(4): 802-806.

[17] Zhang MH, Liu Y. Rearch on Work-Flow Management Technology[J]. Information Security and Technology, 2011, 11: 45-46.

[18] Zeng ZL, Song YP, Yang GX, et al. Fluorine Benzene Nicol, Compared with The Curative Effect of Chloromycetin on Chicken Escherichia Coli[J]. Chinese Journal of Veterinary Science and Technology, 2001, 8(31): 25-27.

[19] Zang MH, Zhao XK. Research on Work-flow Technology Based on Collaborative Commerce Platform[J]. Intelligent Computer and Applications, 2011, 12: 60-63.

[20] Guo H, Zhang D, Li C, et al. Self-assembled Nanoparticles Based on Galactosylated O-Carboxymethyl Chitosan-Graft-Stearic Acid Conjugates for Delivery of Doxorubicin[J]. International Journal Pharmaceutics, 2013, 458: 31-38.

[21] Zhang JP, Hu HY, Zhang ZQ. Studies on Florfenicol Absorption Characteristics in Rat Intestine[J]. Chinese Journal of Veterinary Medicine, 2013, 49(6): 71-75.